Aguilera, Isabel <br/><br/>
Choice of calcineurin inhibitor may influence the development of de novo immune hepatitis associated with anti-GSTT1 antibodies after liver transplantation.  [electronic resource] 

 -  Clinical transplantation   
 - 207-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1399-0012 
<br/><br/><label>Standard No.: </label>10.1111/j.1399-0012.2010.01221.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antibodies, Anti-Idiotypic--adverse effects<br/>Calcineurin--adverse effects<br/>Female<br/>Glutathione Transferase--immunology<br/>Hepatitis, Autoimmune--etiology<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Liver Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Survival Rate<br/>Young Adult